| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 955,667 | 890,449 | 1,283,284 | 1,299,735 | | Cost of Revenue | 566,831 | 553,419 | 729,708 | 755,362 | | | Gross Profit | 388,836 | 337,030 | 553,576 | 544,373 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 328,671 | 306,159 | 425,546 | 420,352 | | Non Recurring | (2,925) |
-
| 1,154,474 | (9,766) | | Others | 24,166 | 25,392 | 28,581 | 25,412 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 38,924 | 5,479 | (1,055,025) | 108,375 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,237 | (26,950) | 576 | 4,400 | | Earnings Before Interest And Taxes | 38,418 | (31,668) | (1,062,838) | 110,139 | | Interest Expense | 47,418 | 34,798 | 40,301 | 42,290 | | Income Before Tax | (9,000) | (66,466) | (1,103,139) | 67,849 | | Income Tax Expense | 4,706 | (12,047) | (13,683) | 37,701 | | Minority Interest |
-
|
-
| 45,819 | 772 | | | | Net Income From Continuing Ops | (13,706) | (54,419) | (1,089,456) | 30,148 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 10,225 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,706) | (54,419) | (1,089,456) | 40,373 | | Preferred Stock And Other Adjustments | 7,069 | 17,730 |
-
|
-
| | | Net Income Applicable To Common Shares | ($6,637) | ($36,689) | ($1,089,456) | $40,373 |
|
0.04% Nasdaq 
0.26%
Income Statement
